![](/img/cover-not-exists.png)
The broad-spectrum receptor tyrosine kinase inhibitor dovitinib suppresses growth of BRAF -mutant melanoma cells in combination with other signaling pathway inhibitors
Langdon, Casey G., Held, Matthew A., Platt, James T., Meeth, Katrina, Iyidogan, Pinar, Mamillapalli, Ramanaiah, Koo, Andrew B., Klein, Michael, Liu, Zongzhi, Bosenberg, Marcus W., Stern, David F.Volume:
28
Language:
english
Journal:
Pigment Cell & Melanoma Research
DOI:
10.1111/pcmr.12376
Date:
July, 2015
File:
PDF, 2.64 MB
english, 2015